These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10482825)

  • 21. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
    J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double-blind study.
    Ogirala RG; Sturm TM; Aldrich TK; Meller FF; Pacia EB; Keane AM; Finkel RI
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1461-6. PubMed ID: 7582277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.
    Denning DW; O'Driscoll BR; Powell G; Chew F; Atherton GT; Vyas A; Miles J; Morris J; Niven RM
    Am J Respir Crit Care Med; 2009 Jan; 179(1):11-8. PubMed ID: 18948425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma.
    Massanari M; Kianifard F; Zeldin RK; Geba GP
    Allergy Asthma Proc; 2009; 30(5):534-9. PubMed ID: 19467177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Aoshiba K; Tagaya E; Nakata J; Isono K; Nagai A
    Lancet; 2000 Jul; 356(9226):273-8. PubMed ID: 11071181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L; Azizzadeh M; Jafari P
    J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tinea capitis due to Trichophyton rubrum in a 3-month-old infant.
    Valari M; Stefanaki C; Karteri G; Zarkadi E; Katsambas A
    Mycoses; 2006 Sep; 49(5):439-40. PubMed ID: 16922801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma.
    Kishiyama JL; Valacer D; Cunningham-Rundles C; Sperber K; Richmond GW; Abramson S; Glovsky M; Stiehm R; Stocks J; Rosenberg L; Shames RS; Corn B; Shearer WT; Bacot B; DiMaio M; Tonetta S; Adelman DC
    Clin Immunol; 1999 May; 91(2):126-33. PubMed ID: 10227804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study.
    Gupta AK; Dlova N; Taborda P; Morar N; Taborda V; Lynde CW; Konnikov N; Borges M; Raboobee N; Summerbell RC; Adam P; Hofstader SL; Aboobaker J
    Br J Dermatol; 2000 May; 142(5):965-8. PubMed ID: 10809856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.
    van den Berge M; Arshad SH; Ind PW; Magnussen H; Hamelmann E; Kanniess F; Postma DS
    Respir Med; 2009 Aug; 103(8):1216-23. PubMed ID: 19297141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies.
    Abuan T; Yeager M; Montgomery AB
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):381-8. PubMed ID: 20958143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
    Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M
    Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC; Pujet JC
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.